Your browser doesn't support javascript.
loading
Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate.
Rodríguez-Bejarano, Oscar Hernán; Roa, Leonardo; Vargas-Hernández, Giovanni; Botero-Espinosa, Lucía; Parra-López, Carlos; Patarroyo, Manuel Alfonso.
Affiliation
  • Rodríguez-Bejarano OH; Health Sciences Faculty, Universidad de Ciencias Aplicadas y Ambientales (U.D.C.A), Calle 222#55-37, Bogotá 111166, Colombia; Molecular Biology and Immunology Department, Fundacion Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá 111321, Colombia; PhD Programme in Biotechnology
  • Roa L; Veterinary Clinic, Faculty of Agricultural Sciences, Universidad de La Salle, Carrera 7 #179-03, Bogotá 110141, Colombia.
  • Vargas-Hernández G; Animal Health Department, Faculty of Veterinary Medicine and Zootechnics, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá 111321, Colombia.
  • Botero-Espinosa L; Animal Health Department, Faculty of Veterinary Medicine and Zootechnics, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá 111321, Colombia.
  • Parra-López C; Microbiology Department, Faculty of Medicine, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá 111321, Colombia. Electronic address: caparral@unal.edu.co.
  • Patarroyo MA; Molecular Biology and Immunology Department, Fundacion Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá 111321, Colombia; Microbiology Department, Faculty of Medicine, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá 111321, Colombia. Electronic address: mapatarr.fidi
Biochim Biophys Acta Rev Cancer ; 1879(1): 189064, 2024 01.
Article in En | MEDLINE | ID: mdl-38158026
ABSTRACT
The tumour microenvironment (TME) is usually defined as a cell environment associated with tumours or cancerous stem cells where conditions are established affecting tumour development and progression through malignant cell interaction with non-malignant cells. The TME is made up of endothelial, immune and non-immune cells, extracellular matrix (ECM) components and signalling molecules acting specifically on tumour and non-tumour cells. Breast cancer (BC) is the commonest malignant neoplasm worldwide and the main cause of mortality in women globally; advances regarding BC study and understanding it are relevant for acquiring novel, personalised therapeutic tools. Studying canine mammary gland tumours (CMGT) is one of the most relevant options for understanding BC using animal models as they share common epidemiological, clinical, pathological, biological, environmental, genetic and molecular characteristics with human BC. In-depth, detailed investigation regarding knowledge of human BC-related TME and in its canine model is considered extremely relevant for understanding changes in TME composition during tumour development. This review addresses important aspects concerned with different methods used for studying BC- and CMGT-related TME that are important for developing new and more effective therapeutic strategies for attacking a tumour during specific evolutionary stages.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mammary Neoplasms, Animal / Mammary Glands, Human Limits: Animals / Female / Humans Language: En Journal: Biochim Biophys Acta Rev Cancer Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mammary Neoplasms, Animal / Mammary Glands, Human Limits: Animals / Female / Humans Language: En Journal: Biochim Biophys Acta Rev Cancer Year: 2024 Document type: Article